CHU de Grenoble

Phase	Trial	Trial Status	Site Status	Drug [desc]	NCT#
1/2	[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake (NeoRay)	Recruiting	Active	neoBOMB1	NCT03872778